Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

COUGH RELIEF SYRUP 100 mg/5 ml - HSA Drug Approval Details

Approvals/HSA/COUGH RELIEF SYRUP 100 mg/5 ml

Approved

THERAPEUTIC

COUGH RELIEF SYRUP 100 mg/5 ml

SYARIKAT WEN KEN DRUG SDN BHD🇸🇬 Health Sciences Authority

Approval Date: Oct 21, 1996
Approval ID: 9baab7dc18661211
Company: SYARIKAT WEN KEN DRUG SDN BHD
Type: Therapeutic

Approval Details

Approval Id: 9baab7dc18661211
Drug Name: COUGH RELIEF SYRUP 100 mg/5 ml
Product Name: COUGH RELIEF SYRUP 100 mg/5 ml
Approval Number: SIN08969P
Approval Date: 1996-10-21
Registrant: WEN KEN MARKETING (S) PTE LTD
Licence Holder: WEN KEN MARKETING (S) PTE LTD
Drug Type: Therapeutic
Forensic Classification: General Sale List
Dosage Form: SYRUP
Route Of Administration: ORAL
Atc Code: R05CA03
Atc Item Name: guaifenesin
Pharma Manufacturer Name: WEN KEN MARKETING (S) PTE LTD
Company Detail Path: /organization/wen-ken-marketing-s-pte-ltd

Active Ingredients

GUAIPHENESIN

100 mg/ 5 ml

GUAIPHENESIN

100 mg/ 5 ml

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Oct 21, 1996

Approval ID

9baab7dc18661211

Type

Therapeutic

Back to HSA Approvals